Paraneoplastic cerebellar degeneration associated with ovarian cancer

por RUSSO, ALESSIA ERIKA, SCALONE, SIMONA, LEONARDI, GIULIA COSTANZA, SCALISI, AURORA, GIORDA, GIORGIO, SORIO, ROBERTO
Publicado 2013

A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation...

por Posocco, Bianca, Buzzo, Mauro, Follegot, Andrea, Giodini, Luciana, Sorio, Roberto, Marangon, Elena, Toffoli, Giuseppe
Publicado 2018

Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis

por Garziera, Marica, Montico, Marcella, Bidoli, Ettore, Scalone, Simona, Sorio, Roberto, Giorda, Giorgio, Lucia, Emilio, Toffoli, Giuseppe
Publicado 2015

Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives

por Dall’Acqua, Alessandra, Bartoletti, Michele, Masoudi-Khoram, Nastaran, Sorio, Roberto, Puglisi, Fabio, Belletti, Barbara, Baldassarre, Gustavo
Publicado 2021

Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study

por Giorda, Giorgio, Gadducci, Angiolo, Lucia, Emilio, Sorio, Roberto, Bounous, Valentina E, Sopracordevole, Francesco, Tinelli, Andrea, Baldassarre, Gustavo, Campagnutta, Elio
Publicado 2014

TIMP-1 Is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells

por Sonego, Maura, Poletto, Evelina, Pivetta, Eliana, Nicoloso, Milena S., Pellicani, Rosanna, Rampioni Vinciguerra, Gian Luca, Citron, Francesca, Sorio, Roberto, Mongiat, Maurizio, Baldassarre, Gustavo
Publicado 2019

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

por Bartoletti, Michele, Pelizzari, Giacomo, Gerratana, Lorenzo, Bortot, Lucia, Lombardi, Davide, Nicoloso, Milena, Scalone, Simona, Giorda, Giorgio, Baldassarre, Gustavo, Sorio, Roberto, Puglisi, Fabio
Publicado 2020

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach

por Garziera, Marica, Roncato, Rossana, Montico, Marcella, De Mattia, Elena, Gagno, Sara, Poletto, Elena, Scalone, Simona, Canzonieri, Vincenzo, Giorda, Giorgio, Sorio, Roberto, Cecchin, Erika, Toffoli, Giuseppe
Publicado 2019

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells

por Sonego, Maura, Pellizzari, Ilenia, Dall’Acqua, Alessandra, Pivetta, Eliana, Lorenzon, Ilaria, Benevol, Sara, Bomben, Riccardo, Spessotto, Paola, Sorio, Roberto, Gattei, Valter, Belletti, Barbara, Schiappacassi, Monica, Baldassarre, Gustavo
Publicado 2017

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)

por Garziera, Marica, Cecchin, Erika, Giorda, Giorgio, Sorio, Roberto, Scalone, Simona, De Mattia, Elena, Roncato, Rossana, Gagno, Sara, Poletto, Elena, Romanato, Loredana, Ecca, Fabrizio, Canzonieri, Vincenzo, Toffoli, Giuseppe
Publicado 2019

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)

por Garziera, Marica, Cecchin, Erika, Canzonieri, Vincenzo, Sorio, Roberto, Giorda, Giorgio, Scalone, Simona, De Mattia, Elena, Roncato, Rossana, Gagno, Sara, Poletto, Elena, Romanato, Loredana, Sartor, Franca, Polesel, Jerry, Toffoli, Giuseppe
Publicado 2018

A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer

por Pignata, Sandro, Scambia, Giovanni, Villanucci, Alessandro, Naglieri, Emanuele, Ibarbia, Mikel Arruti, Brusa, Federica, Bourgeois, Hugues, Sorio, Roberto, Casado, Antonio, Reichert, Dietmar, Dopchie, Catherine, De Rivas, Beatriz, de Sande, Luis Miguel
Publicado 2021

An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer

por Bartoletti, Michele, Giorda, Giorgio, Viel, Alessandra, Fornasarig, Mara, Zdjelar, Adrian, Segatto, Enrica, Sorio, Roberto, Corsetti, Serena, Scalone, Simona, Nicoloso, Milena Sabrina, Pivetta, Tania, Lucia, Emilio, Clemente, Nicolò, Palazzari, Elisa, Canzonieri, Vincenzo, Puglisi, Fabio
Publicado 2022

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation

por Dall'Acqua, Alessandra, Sonego, Maura, Pellizzari, Ilenia, Pellarin, Ilenia, Canzonieri, Vincenzo, D'Andrea, Sara, Benevol, Sara, Sorio, Roberto, Giorda, Giorgio, Califano, Daniela, Bagnoli, Marina, Militello, Loredana, Mezzanzanica, Delia, Chiappetta, Gennaro, Armenia, Joshua, Belletti, Barbara, Schiappacassi, Monica, Baldassarre, Gustavo
Publicado 2017

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 rand...

por Pignata, Sandro, Scambia, Giovanni, Savarese, Antonella, Breda, Enrico, Scollo, Paolo, De Vivo, Rocco, Rossi, Emanuela, Gebbia, Vittorio, Natale, Donato, Del Gaizo, Filomena, Naglieri, Emanuele, Ferro, Antonella, Musso, Pietro, D'Arco, Alfonso Maria, Sorio, Roberto, Pisano, Carmela, Di Maio, Massimo, Signoriello, Giuseppe, Annunziata, Annalisa, Perrone, Francesco
Publicado 2006

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

por Pignata, Sandro, Ferrandina, Gabriella, Scarfone, Giovanna, Scollo, Paolo, Odicino, Franco, Cormio, Gennaro, Katsaros, Dionyssios, Villa, Antonella, Mereu, Liliana, Ghezzi, Fabio, Manzione, Luigi, Lauria, Rossella, Breda, Enrico, Alletti, Desiderio Gueli, Ballardini, Michela, Lombardi, Alessandra Vernaglia, Sorio, Roberto, Mangili, Giorgia, Priolo, Domenico, Magni, Giovanna, Morabito, Alessandro
Publicado 2008

Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC

por Perrone, Francesco, Baldassarre, Gustavo, Indraccolo, Stefano, Signoriello, Simona, Chiappetta, Gennaro, Esposito, Franca, Ferrandina, Gabriella, Franco, Renato, Mezzanzanica, Delia, Sonego, Maura, Zulato, Elisabetta, Zannoni, Gian F., Canzonieri, Vincenzo, Scambia, Giovanni, Sorio, Roberto, Savarese, Antonella, Breda, Enrico, Scollo, Paolo, Ferro, Antonella, Tamberi, Stefano, Febbraro, Antonio, Natale, Donato, Maio, Massimo Di, Califano, Daniela, Scognamiglio, Giosuè, Lorusso, Domenica, Canevari, Silvana, Losito, Simona, Gallo, Ciro, Pignata, Sandro
Publicado 2016

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer

por Viotto, Davide, Russo, Francesca, Anania, Ilaria, Segatto, Ilenia, Rampioni Vinciguerra, Gian Luca, Dall'Acqua, Alessandra, Bomben, Riccardo, Perin, Tiziana, Cusan, Martina, Schiappacassi, Monica, Gerratana, Lorenzo, D'Andrea, Sara, Citron, Francesca, Vit, Filippo, Musco, Lorena, Mattevi, Maria Chiara, Mungo, Giorgia, Nicoloso, Milena S, Sonego, Maura, Massarut, Samuele, Sorio, Roberto, Barzan, Luigi, Franchin, Giovanni, Giorda, Giorgio, Lucia, Emilio, Sulfaro, Sandro, Giacomarra, Vittorio, Polesel, Jerry, Toffolutti, Federica, Canzonieri, Vincenzo, Puglisi, Fabio, Gattei, Valter, Vecchione, Andrea, Belletti, Barbara, Baldassarre, Gustavo
Publicado 2020